Financials

News Discussions Technicals Seasonals

6978 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to IMMUNOTECH BIOPHARM LTD operating, investing, and financing activities

6978 free cash flow for H1 24 is -107.05 M HKD. For 2023, 6978 free cash flow was -205.96 M HKD and operating cash flow was -187.11 M HKD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—